Raviplaan

Raviplaan is a term used in Estonian healthcare to describe a structured plan for pharmacotherapy for a patient. It outlines the rationale for medications, the intended treatment goals, the specific medicines to be used, dosages and routes of administration, expected duration, and plans for monitoring and adjustment as needed.

The primary purpose of a raviplaan is to coordinate care across providers, improve medication safety, support adherence, and enable timely modifications in response to changes in the patient’s condition or tolerability. It serves as a reference for clinicians, patients, and caregivers to understand how therapy is to proceed and when to reevaluate effectiveness or safety.

Core components typically include the diagnosed condition or indications, chosen medications with dosing schedules, potential alternatives, expected outcomes, and discontinuation or tapering plans. A raviplaan also contains a monitoring strategy (laboratory tests, vital signs, symptom checks), safety considerations (drug interactions, allergies, contraindications), and patient education or adherence supports. Documentation may note responsibilities of different team members, such as physicians, pharmacists, and nurses.

Development often involves multidisciplinary input and is guided by clinical guidelines, local formulary rules, and patient preferences. It is usually recorded in the patient’s electronic health record and reviewed at regular intervals or at care transitions, such as hospital discharge, primary care visits, or during acute events.

In practice, raviplaan is used across settings—primary care, hospital care, and long-term management of chronic diseases—where systematic pharmacotherapy planning supports safer, more effective treatment. See also pharmacotherapy, care plan, and medication reconciliation.